Skip to Content

Tibet Pharmaceuticals Inc TBET

Morningstar Rating
$0.00 0.00 (0.00%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

TBET is trading at a 393% premium.
Price
$0.00
Fair Value
$8.32
Uncertainty
Extreme
1-Star Price
$8.18
5-Star Price
$8.22
Economic Moat
Rmyqls
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if TBET is a good fit for your portfolio.

Trading Information

Previous Close Price
$0.00
Day Range
$0.000.00
52-Week Range
$0.000.00
Bid/Ask
$0.00 / $0.01
Market Cap
$14.85
Volume/Avg
8,000 / 8,000

Key Statistics

Price/Earnings (Normalized)
Price/Sales
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Tibet Pharmaceuticals Inc is a specialty pharmaceutical company focusing on the research, development, manufacturing and marketing of modernized traditional Tibetan medicines.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Stock Style Box
Small Value
Total Number of Employees
221

Valuation

Metric
TBET
Price/Earnings (Normalized)
Price/Book Value
Price/Sales
Price/Cash Flow
Price/Earnings
No chart available

Financial Strength

Metric
TBET
Quick Ratio
13.90
Current Ratio
14.48
Interest Coverage
159.97
Quick Ratio
No chart available

Profitability

Metric
TBET
Return on Assets (Normalized)
27.22%
Return on Equity (Normalized)
31.09%
Return on Invested Capital (Normalized)
30.34%
Return on Assets
No chart available
See how this stock stacks up to its competitors with Morningstar Investor

Drug Manufacturers - Specialty & Generic Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Zoetis Inc Class A
ZTS
XrssqlbhcvBtrmp$82.1 Bil
Merck KGaA ADR
MKKGY
XhbqxcstqYqfwd$75.2 Bil
Haleon PLC ADR
HLN
DclbwbyxkCdbwf$41.4 Bil
Viatris Inc
VTRS
SlngqfgMvjc$14.4 Bil
Dr Reddy's Laboratories Ltd ADR
RDY
ClsysjdkVdgm$13.7 Bil
Catalent Inc
CTLT
TffgfsrwmTfhjy$10.6 Bil
Perrigo Co PLC
PRGO
LhwfhgbwhCbbk$3.8 Bil
Prestige Consumer Healthcare Inc
PBH
SbkcbqtCvyhns$3.5 Bil
Curaleaf Holdings Inc
CURLF
YjscxcffBrwy$3.0 Bil
Green Thumb Industries Inc
GTBIF
YgylfrgllVnkh$2.7 Bil

Sponsor Center